Nifedipine vs Placebo for Maintenance Tocolysis of Preterm Labor.
Information source: Stanford University
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Obstetric Labor, Premature; Venous Thrombosis
Intervention: Nifedipine (Drug)
Phase: N/A
Status: Completed
Sponsored by: Stanford University Official(s) and/or principal investigator(s): Yasser Yehia El-Sayed, Principal Investigator, Affiliation: Stanford University
Summary
Comparing nifedipine to placebo for the maintenance tocolysis of preterm labor
Clinical Details
Official title: Nifedipine for the Maintenance Tocolysis of Preterm Labor: Comparison to Placebo in a Prospective, Randomized Double Blind Trial
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
Primary outcome: Achieving 37 weeks gestation
Secondary outcome: Incidence of recurrent preterm laborNeonatal outcomes
Detailed description:
To estimate whether maintenance nifedipine tocolysis after arrested preterm labor prolongs
pregnancy and improves neonatal outcomes.
Eligibility
Minimum age: 18 Years.
Maximum age: 55 Years.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- arrested preterm labor
Exclusion Criteria:
- ruptured membranes, fetal distress, placenta previa, placental abruption, maternal
medical contraindication to tocolysis
Locations and Contacts
Stanford University School of Medicine, Stanford, California 94305, United States
Additional Information
Starting date: November 2001
Last updated: June 10, 2011
|